Breast cancer (BC) and diabetes mellitus are the most important risk and development factors in modern oncology. The study looked at molecular breast cancer subtypes in patients with and without diabetes. It was discovered in our study that patients with diabetes have a higher frequency of luminal subtypes and lower receptioni. As a result, these factors, when combined with early and timely diagnosis, can increase the observed 5-year survival rate in diabetic patients. However, in the presence of DM combined with metabolic disorders, the survival rate is significantly lower. As a result of these factors, combined with early and timely diagnosis,
Author (S) Details
V. G. Cherenkov
Institute of Medical Education of the Novgorod University named Yaroslav the Wise, Regional Oncological Dispensary, Veliky Novgorod, Russia.
B. B. Frumkin
Mammological Department, Regional Oncological Dispensary, Veliky Novgorod, Russia.
K. G. Pasevich
Institute of Medical Education of the Novgorod University named Yaroslav the Wise, Regional Oncological Dispensary, Veliky Novgorod, Russia.
A. A. Ivanov
Regional Oncological Dispensary, Veliky Novgorod, Russia.
View Book :- https://stm.bookpi.org/HMMS-V4/article/view/1699
No comments:
Post a Comment